NK cells not only target cancer cells via single-chain antibody recognition of tumor surface antigens but also detect various ligands through multiple receptors, including NCRs, NKG2D, co-stimulatory receptor DNAM-1 (CD226), and some activating KIRs [134]. This evidence concerns the gene CD226 and cancer.